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INTRODUCTION 
Schizophrenia is a psychiatric disorder with a mostly continuous 
course. The chronic phase in schizophrenia is characterized most of the 
time by multiple exacerbations. It is estimated that schizophrenia 
decreases the life expectancy of patients by approximately 10 years. A life 
time morbid risk of schizophrenia of 0.7% for all persons in birth cohort 
(Saha et al. 2005). Approximate hospital readmission rate has been 
observed to be about 40 to 60% in schizophrenia patients within 2 years 
after the first hospital admission.(Benjamin et al) In a systematic review 
of more than 100 epidemiological studies in 32 countries, the median 
incidence rate was 15.2 per 100,000 persons per year (McGrath et al. 
2004). Suicide is a major cause for premature death in schizophrenia. 
Suicide is also the most unpredictable clinical outcome in schizophrenia, 
though it is also generally considered to be a preventable one. Suicide and 
suicidal ideations in schizophrenia have multiple etiological factors. 
Identification of the risk factors can help reduce the incidence of suicidal 
ideation and thereby suicides in schizophrenia, which in turn may lead to 
a better outcome in schizophrenia. About 10% of patients will have 
persistent, unremitting psychosis (Wiersma et al,1998). 
In this study, we have attempted to analyse the prevalence and the 
associated factors of suicidal ideation in patients with schizophrenia, and 
to observe the differences between the group of patients with suicidal 
ideation and those without suicidal ideation, to recognition of risk factors. 
REVIEW OF LITERATURE 
 Schizophrenia is considered a group of disorders or as a syndrome 
with a heterogeneous etiology. It affects the thought, perception, 
emotions, cognitive ability and behavioural pattern of the patients. The 
illness usually begins before the age of 25 years and run through one's 
entire life. It affects persons of all social classes. (Benjamin et al). Life 
time prevalence is 1% in general population. The word 'schizophrenia' 
was coined by Eugene Bleuler (1857-1939). The term of schizophrenia 
meaning was „splitting of the mind‟. Bleuler also described the primary 
symptoms of schizophrenia which are called the “4A symptoms”. 
4A Symptoms: 
1. Association 
2. Affect 
3. Autism 
4. Ambivalence        
(Benjamin et al) 
Kurt Schneider described certain symptoms which he grouped as 
first rank and second rank. Schneider's criteria for the diagnosis of 
schizophrenia had lasting impression in psychiatric practice. ICD-10 
guidelines use Schneider's criteria heavily. 
Not single, but multiple genetic factors and environmental factors 
may influence the occurring of schizophrenia. Long periods of 
hospitalization and more chronic course of illness associated with 
decreased intellectual functioning. Schizophrenia has higher association 
with other psychiatric illnesses like substance use disorder, depression, 
OCD, PTSD and others. Suicide risks are more in schizophrenic patients. 
10% of schizophrenic patients die by suicide. (Harris et al). Most patients 
commit suicide in the early illness period. Schizophrenia patients mostly 
have only a partial insight or may have a total loss of insight. Treatment 
of schizophrenia can be challenging. 
EPIDEMIOLOGY: 
The life time prevalence of schizophrenia is almost 1 percent 
worldwide. Schizophrenia affects men and women almost equally. In 
men, the usual age of onset is about 10-25years. In women, onset is 25 to 
35 years. It is very rare before the age of 10 years and after age of 60 
years. (Benjamin et al) Women have been found to have better 
functioning before the onset of disease compared to male schizophrenia 
patients. Male patients suffered more from negative symptoms than 
women patients do. In general overall outcome is better for female than 
male schizophrenic patients. (Benjamin et al) 
  
RISK FACTORS: 
The following are the risk factors for schizophrenia: 
Genetic loading – family history of schizophrenia 
Being born in winter period 
High level of expressed emotion in family 
Being born to a father who is more than 60 years old 
Disturbance in mother-child relationship has been observed to have 
a 6 times higher risk for schizophrenia. 
Family conflicts and pathological family behaviour increase 
emotional stress. Increased emotional stress leads to increased risk for 
schizophrenia. Higher relapse rates are seen in schizophrenia patients 
who experience high levels of expressed emotions from others. Almost 
50% of beds are occupied by schizophrenia patients in psychiatric homes. 
Hypothyroidism - 3 times greater risk (Tasman et al )                          
Some reports of increased incidence among people born during 
influenza epidemics ( Morgan et al 1997) 
GENETIC FACTORS IN SCHIZOPHRENIA: 
Genetics has a major role in the development of schizophrenia. 
There may be multiple genes, with varying levels of effects, interacting 
with each other and with other risk factors. (Cf. Mowry and nancarrow 
2001, Maier et al, 2006). 
First degree relatives like parents or siblings have chance increased 
risk of 10%. Monozygotic twin have the highest risk – the unaffected 
twins have a risk of 50%.  Among second degree relatives the risk is 6 
times higher and among third degree relatives the risk is two times higher 
(Tsuang et al 2001). 
ADOPTION STUDIES: 
Adoption studies done in Denmark, conducted in the 1960s - 70s 
providing compelling evidence that adoptees with schizophrenia had 
higher rates of schizophrenia in their biological relatives (5.6%) than 
adoptees without schizophrenia (0.9%) (Ingraham and Kety 2000). 
IMMIGRANTS: 
Epigenetic mechanism could explain the increased risk in 
immigrants (Dealberto 2010). 
BIRTH COMPILICATIONS: 
A higher rate of pregnancy and birth complication has been 
observed in schizophrenia. (Canon et al 2002) 
SEX:  
The onset of schizophrenia is on an average 3.5 to 6 years earlier in 
men than in women (Riecher- rossler and hafrer 2000)  
No difference for males versus females. (MC Grath et al 2008) 
  
INDUSTRIALIZATION: 
Incidence rates for schizophrenia by urban city found that the risk 
for schizophrenia was 2.37 times greater in the urban compared to the 
rural population (vassos et al 2012). 
NEUROTRANSMITTERS INVOLVED IN THE PATHOGENESIS 
OF SCHIZOPHRENIA: 
Dopamine 
Serotonin 
Norephinephrine 
Neuropeptides 
Glutamate 
Acetylcholine 
Multi-neurotransmitter theory about schizophrenia has been 
explained by carlssom and colleques 2001. 
Positive symptoms are described to be due to dysfunction in the 
Anterior cingulate region, basal ganglia and the thalamo cortical circuit. 
Negative symptoms are considered to be due to dysfunction in the   
Dorso lateral pre frontal cortex. 
No definite findings have been observed.  No definite laboratory 
investigation or findings have been observed. 
SUBSTANCE USE IN SCHIZOPHRENIA: 
Substance abuse is more common in schizophrenia patients than in 
general population. Life time prevalence rate of alcohol abuse in 
schizophrenia patients is almost 40percent. About 90% of schizophrenia 
patients are misused nicotine. Nicotine may improve illness symptoms 
and also act as time filler for those patients. In schizophrenic patients 
associated co-morbid with substance misuse in life time prevalence 
almost 50%.  
Schizophrenia patients are most commonly misused nicotine. 
(Benjamin et al) 
Smoking rates among individuals diagnosed with schizophrenia are 
much higher than those in the general population (De Leon and Diaz 
2005) 
Auditory sensory gating systems are decreased by alpha 7 nicotinic 
receptors in schizophrenic population.  Than the nicotine systems may be 
involved in the pathology of schizophrenia suggests possible biological 
underpinnings to the high smoking rates. (Leonard et al, 2007) 
Psychologically, studies have suggested that individuals with 
schizophrenia may smoke to self-medicate illness symptoms. (Lucksted 
et al, 2004) 
Greater severity of substance abuse was associated with greater 
impairment. (Kerfoot et al, 2011) 
LATE ONSET SCHIZOPHRENIA: 
And if schizophrenia occurs after the age of 45 years, it is referred 
to as late onset of schizophrenia, and is thought to be associated with 
formal thought disorder and negative symptoms are considered to be very 
rare.  (Howard et al 2000). Late onset schizophrenia is more common in 
women (Howard et al 2000). 
DEPRESSION IN SCHIZOPHRENIA: 
Depression is common in schizophrenia – almost 25%, and this 
condition leads to poor treatment outcome, reducing functioning level, 
high relapse rate, re-hospitalization and suicide (siris 2000). Eugene 
bleuler described depression to be one of the core symptoms of 
schizophrenia. 
Females have higher risk. Depressed females mostly associated 
with negative symptoms and depressed male patients are mostly 
associated with positive symptoms of schizophrenia. 
Early parental loss is more common (Roy et al 1983) 
Depressive symptoms are equally common in male and female 
patients (Addington et al 1996) 
Association between depressive symptoms and attention 
impairment - frontal lobe dysfunction(Kohler et al 1998 a ) 
Increased bilateral temporal lobe volumes and decreased laterality 
(Kohler et al 1998b) 
Neuroimaging of depression with schizophrenia and depression 
almost same features.       
Depression in schizophrenia can be detected using standard 
diagnostic check list (Mulrow et al 1995). 
DEPRESSION AND HOPELESSNESS: 
Persistent depressed mood, particularly feelings of hopelessness 
and psycho-motor disturbance, were significantly associated with suicide 
in a prospective us study of 104 schizophrenic patients, 15 of when 
subsequently committed suicide. (Drake, R.E. et al). 
Schizophrenia patients not voluntarily express theirs suicidal ideas, 
so clinician should ask directly about patient's suicidal ideas. Negative 
symptoms of schizophrenia may be confused with depression.  Sadness is 
also an inconsistent feature in depression with schizophrenic individuals 
or patients. 
Schizophrenia directly producing negative symptoms are called 
primary negative symptoms, drugs and environmental factors producing 
negative symptoms are called secondary negative symptoms.  About 15% 
of first episodic schizophrenia may have depression. 25 to 30% of chronic 
condition of schizophrenia may have depression. A global assessment 
scale score of less than 51 (serious symptoms) was found in 34 - 70% in 
schizophrenia patients (Lang et al 2013). 
There is no difference in a depressive features due to bereavement 
and that due to other significant life problems (Wake field et al 2007, 
Kendler et al 2008). 
People who have recurrent brief episodes and also episodes of 
typical duration have been found to be at heightened risk for suicide 
attempts (Pezawas et al., 2003). 
Distinguishing between depression and negative symptoms is 
important because depression is a risk factor for suicide, whereas 
negative symptoms are relatively protective (Siris 2000). 
DEPRESSION AND SUICIDE  
 In a psychological autopsy study of a series of 100 suicide victims, 
64 could be diagnosed post-mortem with uncomplicated major depression 
(Barraclough et al., 1974) 
Suicide risk is particularly acute early in the course of 
antidepressant treatment, and has thus fueled a raging controversy about 
the safely of antidepressant therapy for depression (Healy & Whitaker, 
2003). 
However, an analysis of over 370 antidepressant drug trials found 
no excess suicide deaths and a modest elevation in suicidal behaviour 
(Stone et al., 2009). 
Globally schizophrenia is the fifth leadings cause of years lost to 
disability for men and the sixth leading cause for women (World Health 
Organization 2008).   
About 10 % of patients will have persistent, unremitting psychosis 
(Wiersma et al 1998) 
PERSONALITY FACTORS: 
Greater neurotism may also predispose to depression (kindler et al, 
Costa et al 2005). Elevated neurotism – strong predictor of depression 
during six years of follow up (Shea et al 1996)  
Depression can occur in those not on antipsychotic drugs. (Johnson 
1981a). Still, the prevalence of significant depression reduces with 
treatment. (Hirsch et al 989). General functioning after treatment for 
depression still may never return to normalcy. (kennedy and foy 2005). 
DEPRESSION AS A PRODROMAL SYNDROME: 
Depression was common in the pro-dromal stage of schizophrenia 
(Herz and Melville et al). Symptoms most frequently observed are 
reduced food intake, poor cognition, insomnia, depression and loneliness. 
         
DEPRESSION IN CHRONIC SCHIZOPHRENIA: 
Chronic stage - less chance for depressive episode. 
Positive symptoms in chronic stage may cause distress and 
depression. 
Depression is a risk factor for suicide in schizophrenic patients. 
(Prasad 1986)  
Depression can be the main reason for 40% of admissions (Falloon 
et al 1978). Patients with post psychotic depression are at higher risk for 
relapse. 
SUICIDE: 
 Suicide is a Latin word meaning „self murder‟. The severity can 
range from suicidal ideation to acting out the ideation. Attempted and 
committed patients many times have had plans for days, weeks, months 
or even years before the attempt. Many studies have documented an 
elevated suicide rate in schizophrenia. These rates have been reported to 
the as low as 2% (Black et al, 1985; Stephens et al, 1999) but more often 
quoted to be between 4% and 13% with frequently accepted modal rate 
being approximately 10% (Miles 1977; Tsuang et al 1978; Drake et al, 
1985;Nyman and johnsson 1986;Roy 1986;Caldwell and gottesman 1990; 
Meltzer and okayli 1995; Fenton et al 1997;  Stephens et al 1997;Inskip et 
al 1998; Wiersma et al, 1998) 
Studies of adults and adolescents who commit suicide in general 
reveal that more than 90 percent of them suffered from at least one 
psychiatric disorder, and as many as 80percent of them had consulted a 
physician in the event. (Moscicki, 2000; Luoma et al 2002) 
Suicide is an emergency condition in the psychiatric field. 
Psychiatrists devote more care to such patients. It is not possible to 
predict suicide accurately or all the time before it is acted out. What is 
done is providing standard care by avoiding or reducing high risk factors 
for suicide. 
Suicide is not an individual problem, it is a social problem. 
Imitation suicide mostly influence select the method of suicide. Suicide 
threatens not only to the individual with his family and also to the society. 
It has a major impact on the survivors. Males are had higher suicidal rate 
than females in worldwide. Despite problem in the recording of suicide, 
reports on suicide rates among different cultures or people suggest a true 
variation in suicide mortality.  (Lonnqvist, J, Sainsbury, p et al) 
Successful suicide prevention calls for sensitive understanding of suicidal 
intent and active early intervention. (Isometsa, E.T. et al) 
Suicide attempts are much less reliably quantified, but have been 
reported among 20-401, of patients diagnosed with schizophrenia by 
modern criteria. (Drake et al, 1985; Fenton et al, 1997; Radomsky et al, 
1999) 
As in other major psychiatric disorder suicide is the leading cause 
of premature death among patients with schizophrenia and other chronic 
psychotic disorders (Black and Fisher 1992, simpson and tusang 1996, de 
hert et al 2001; siris 2001, potkia et al, pinikanana et al 2003) 
WHO survey report was total global mortality rate of suicide in 
worldwide around 2 percent. In young individual unemployment has a 
higher risk or role for suicide. Religion was a one of protective factor for 
suicide. Rapid changes in suicidal behaviour may be protected by cultural 
factors also. Among females, life events as psychosocial stress are less 
strongly connected with suicide. Depression and adverse interpersonal 
life events are more frequent contributors to female than male suicides. 
(Heikkinen, M.E et al) 
 Generally recent life stressors are more risk in male suicidal 
victims than female suicidal victims. Depression of suicide victims differ 
qualitatively from that of living controls; it seems to be more severe and 
accompanied more often by insomnia weight or appetite loss, feelings of 
worthless, inappropriate guilt and thoughts of death or suicidal ideation. 
(McGirr, A. Renaud, J. et al) 
 The mortality risk for suicide in major depression is 20 times that 
expected and 15 to 20 fold in all affective disorders. Every sixth death 
among depressive people treated as psychiatric patients is by suicide. 
(Wulsin et al) The risk is highest for depressive in patients even during 
the post discharge period, and much lower among psychiatric out 
patients, although clearly lowest for those treated for depression in 
primary care. (Simon, G.E. et al) 
 Impulsive and aggressive behaviour, alcohol and drug abuse and 
dependence and cluster B personality disorders increase the risk suicide 
individual with major depression. (Dumais, A. Leasage et al) 
 Suicidal behaviours are linked with mental illnesses especially in 
depressive condition and psychosis with partial insight and co-morbid 
with substance abuse. 
       Suicide attempts: completed suicide ratio is approximately 25:1. 
Suicide rate is higher in adolescents compared to elder population. 
 French sociologist Emile durkheim described three types of 
suicide: 
           1. Egoistic 
          2. Altruistic 
          3. Anomic 
RISK FACTORS: 
Kaplan and harrow have provided prospective evidence that the 
construct of poor overall function, a summation of the factors justed 
noted with emphasis on poor social and work function and poor quality of 
life, is predictive of later suicide.(Kaplan, K.J. et al) 
  
GENDER: 
Committed suicide : 
Male gender 
Male: Female ratio is 4:1 
Attempted suicide: 
Female gender 
Female: Male ratio is 3:1 
Also, males are more likely to use lethal options than females do. 
AGE: 
Younger or teen age is considered to be associated with higher risk. 
Age greater than 45 years 
RACE: 
White people have higher risk. 
RELIGION: 
Low risk has been found in Muslim population. 
Higher risk rate has been in protestants. 
  
MARITAL STATUS: 
Marriage reduce the suicidal risk 
Divorce increase the  suicidal risk 
SEXUAL ORIENTATION:  
 Homosexuals have been found to have high risk. 
OCCUPATION: 
Joblessness - predisposes to suicidal behaviour. 
SOCIAL ECONOMIC STATUS: 
High socio economic status peoples have higher risk for suicide. 
GENETIC FACTORS 
Family H/O attempt or completed suicide. 
PHYSICAL ILLNESS: 
 The Physical illness, especially those which are chronic, are 
important contributing factor for suicide. 
MENTAL ILLNESS: 
Almost all mental illness should contribute increased suicide risk. 
Psychiatric patients have 3 to12 times higher risk of suicide 
compare to non-psychotic patients. 
Schizophrenia contributes about 10% risk.  Depression contributes 
about 80% risk. 
In schizophrenic patients have 10 times higher risk of suicide than 
general population. Higher risk of suicide in first 1 to 2 weeks after 
discharge from the hospital. 
 Out patients are having 3times higher risk of suicide than general 
population 
Personality disorder: ASPD 
Previous impulsive act or violent act. 
Previous history of hospitalization in psychiatric hospital- higher 
risk is observed. 
3 Months period after first suicide attempt is more risky period. 
PRISONERS: 
Suicide 3 times more common in prisoners comparative to general 
population. More than 1/3 had a previous history of psychiatric 
management and suicide attempts. 
CHILDHOOD FACTORS: 
These childhood factors are an increase the risk of later suicidal 
behaviour. 
  
Physical abuse 
Emotional abuse 
Sexual abuse 
Verbal abuse 
RISK FACTORS IN PEOPLE LESS THAN 30 YEARS OF AGE: 
Separation  
Family or peer rejection 
Joblessness 
Medico- legal problem 
RISK FACTORS IN PEOPLE MORE THAN 30 YEARS:  
Physical illness 
RISK FACTORS FOR HIGHER SUICIDE INTENT: 
RISK FACTORS: 
To be male 
Elder peoples  
To be single or separated 
Tryptophan hydroxylase gene, Serotonin transporter gene these two 
genes are mainly involved in the pathogenesis of suicidal behaviour. 
Alcohol and drugs cause misjudgement or impairment and 
decrease the threshold to suicide. Alcohol is detected in about every third 
case at the moment of suicide. (Ohberg, A, vuori et al) The suicide rate in 
heavy drinking is 3.5 times and in alcohol use disorders 10 times higher 
than that in the general population. (Wilcox et al) 
SUICIDE IN SCHIZOPHRENIA: 
The risk in schizophrenia appears to be almost 10 times higher than 
general population. (Harris, E.C et al) The life time risk of suicide in 
schizophrenia is estimated to be 5 percent. (Inskip, H.M.et al, Palmer, 
B.A et al)  Usually suicide not associated with any one of single cause. In 
alcoholic males mostly suicidal behaviour associated with problems with 
wife family conflicts, separated from wife, problems in the working place 
or loss of job and financial issues. Suicidal behaviours mainly influenced 
by environmental factors like social and cultural factors, current 
situational factors and biological and psychological factors and genetic 
factors. 
Risk of suicide in Psychosis is about 10 to 15 fold. Compared to 
other substance abusers alcohol, cannabis and nicotine abusers are having 
lower risk of suicidal behaviour.  
RISK FACTORS: 
Teen age  
Male 
Separation or single after married. 
History of past suicide attempt  
Few weeks after discharge from hospital 
Single or unmarried 
Jobless  
Social isolation 
Living lonely 
Alcohol misuse  
Other substance abuse  
DISEASE RELATED RISK FACTORS: 
Persecutory delusions 
Commend hallucination 
SUICIDAL IDEATION IN SCHIZOPHRENIA: 
RISK FACTORS: 
Difficulty in participating with other human interactions, inferiority 
complex associated with suicidal ideation. 
Disturbance in self awareness 
Altered judgement capacity.  
Specific feature of suicidality in schizophrenic patients are still not 
fully understood. 
Generally Schizophrenic patients had higher risk of suicide.  In 
schizophrenic individuals mostly death caused by suicide almost around 
5%, suicide attempts are associated with almost around 20%. In whole 
life time risk of suicide in schizophrenic patient is around almost 10 to 
15%.  
Suicide risk is increased near illness onset and remains elevated for 
many years after initial treatment, but declines somewhat over time 
(Nielssen et al. 2012) 
          As in the general population, male general, unmarried status living 
alone, unemployment and access to lethal means are risk factors for 
suicide among individuals with schizophrenia (Siris 2001). 
RISK FACTORS: 
Respond to command hallucination 
Higher suicide intent  
Past H/O suicide attempt. 
Risk strongly associated with number of previous attempts, 
especially in females. 
First 3 months period of after the last attempt – critical. 
Age <25 yrs at first attempt. 
Another one study reported schizophrenic individuals mean age of 
death was 33.4 years. Schizophrenic individual with increasing age was 
decreased chance for suicidal act. 
GENDER: 
In general population, commit suicide in male: female ratio 4:1. In 
schizophrenic population this rate was altered. Men : women ratio of 
suicide in schizophrenic patients ware 3:2 
Depression 
Current suicidal ideation 
PREMORBID FUNCTIONING: 
Good pre-morbid level of functioning - higher risk in females 
Poor pre-morbid level of functioning – higher risk in males 
Negative symptoms - significantly lower risk (Fenton et al, 1991). 
But, the loss of social drive, the decreased capacity to feel the 
affect and diminished self awareness may be associated with 
suicide. 
MARITAL STATUS:  
Among women with schizophrenia - ten-fold risk if  
Unmarried, divorced or widowed. 
At the same time, Radomsky et al found that - being separated or 
divorced had no increased risk. 
Lack of regular contact with a significant other - higher risk 
At the same time, female schizophrenic patients are more likely to 
have intact marriages. 
SUBSTANCE USE: 
Alcohol has higher risk of suicide in general. 
But, presence of alcoholism may distinguish suicide completers 
from schizophrenic controls in some studies (Allebeck et al, 1986). 
Another study (Bartels et al) did not support a relationship between 
alcohol use and suicidal behaviour in schizophrenia. For other drugs, 
mixed results have been reported. 
 SOCIAL FACTORS      
Male suicide victims are more violent than female suicide victims. 
Alcohol abused male schizophrenic patients had two times higher suicidal 
risks. 
In schizophrenic male patients mean age of death was 10 to 12 
years younger than female patients. 
  
INSIGHT:  
Awareness of the illness process, negative expectations, low self-
esteem, awareness of restricted ability, dissatisfaction with treatment - 
increases risk (Virkkunen et al). Awareness of delusions, flat mood, 
anhedonia may be especially risky.  General awareness – may not 
increase risk. At the same time, poor awareness may lead to poor 
compliance. (Amador et al, 1993) 
COURSE OF ILLNESS: 
More than 80% of first suicide attempts - within the first 5 years, - 
the risk is high during the initial years (Jill Harkavy, 1999). But, others 
have found that suicide may occur after many years. 
Multiple psychiatric hospitalizations – increases risk. 
A gradual onset of illness. 
First month after discharge. 
Suicide risk is more in acute phase. 83% schizophrenia patients 
may die by suicide before 30 years of age. 
STRESSFUL LIFE-EVENTS: 
Unmarried 
Separated or divorced 
abandonment by parents 
problem in interpersonal relationship 
multi hospitalization 
loss of job 
Recent loss of loved one. 
NEORO-BIOLOGICAL FACTORS: 
Impulsivity, violent activities, aggressive and suicidal behaviour - 
lower CSF 5 –HIAA levels. 
EEG abnormalities during sleep - Decreased REM Latency, 
increased REM duration; sleep EEG changes may predict suicide. 
PREVENTION AND MANAGEMENT: 
There are 2 ways to reduce risk: 
Intensive therapeutic measures during the initial phases. 
In chronic patients, surveillance should be increased in times of 
crises. 
Suicidal behaviour needs multi-determined approach - 
pharmacotherapy and other interventions, hospitalization, crisis service, 
enhancement of family environment and social support. (Vyas N Ahuja). 
  Psychological support mainly consists of supportive therapy, 
family therapy, group therapy and individual therapy.    
          Family support may also influence better treatment outcome.  And 
eliminate or prevent social withdrawal and isolation and help to get a 
stable acceptable environment as main components of psychosocial 
aspects of treatment. 
Emotional or empathic support reduces suicide risk explained by 
drake and colleagues. 
Supportive and rehabilitative measures must be established. 
Depressive features, guilty, workless feelings and anxiety should be 
closely monitored. In any emergency situation or suicidal crises 
readmission must be considered. If patients unwillingness to 
hospitalization the family members should monitors closely 24 hours a 
day. Therapist must available to the patient throughout a day. 
PHARMACOLOGIAL APPROACH: 
Chronically suicidal patients are difficult to treat comparative acute 
suicidal patients. Acute suicidal treatment outcome is mostly favourable.    
Effective anti-depressant or anti-psychotic drugs are should be 
started. The drug risperidone has anti-psychotics and anti-depressant 
effect and it is used if patients have both depressive and psychotic 
features. Suicide may occur in even hospitalized patients. Recovering 
from depressive stage also risk for suicide so closely monitor this 
particular period.    
Early and effective diagnosis and treatments are more useful. 
Psychiatrist should initiate anti-depressants and anti-psychotics treatment 
without hesitation or focus of side effect of anti-psychotic medication. 
First generation anti-psychotics may be associated with increase suicidal 
behaviour. Anti-psychotics alter dopamine and serotonin ratio in the CSF. 
Positive symptoms and acute stage may have high risk. Though negative 
symptoms and the deficit syndrome have reduced risk of suicide, it may 
mask a clinically significant depressive syndrome. (Fenton et al)  
In suicidal risk individuals had 5-hydroxy-indole-acctic acid level 
low in CSF, and high in plasma and urine. 
Clozapine used in treatment resistant schizophrenia, and also used 
to reduce suicidal behaviour. 
CLOZAPINE ROLE WITH SUICIDE:  
Clozapine may have a role or effect of reduce the suicidal 
behaviour. Clozapine more effectively act in treatment resistant 
schizophrenia condition.   When clozapine used in treatment resistant 
condition it reduce suicide attempt rate almost around 2.5% to 3.5%. 
Psychotic symptoms were better controlled, clozapine may have 
antidepressant properties, or patients taking clozapine are seen more 
frequently (due to blood draws) and the clinical contact is protective 
(Siris 2001). 
          Clozapine‟s additional anti-psychotic effects also had decreased 
craving property in cocaine abusers, and decreased craving in alcohol 
abusers, reduced almost overall substance abuse and increased abstinence 
period. 
HOSPITALIZATION: 
If patients have 
any suicidal plan of action 
highly impulsivity behaviour 
lack in strong social support 
BEHAVIORAL AND PSYCHOSOCIAL TREATMENT: 
Empathetic support. 
Acknowledge hopelessness. 
Help establish new tasks. 
To families - support, prevent isolation. 
Cognitive approach help to recognize suicidal urges, seek help 
from friend or therapist. 
Rehabilitative measures 
close monitoring 
Re-admission during crisis. (Drake and others) 
  
AIMS AND OBJECTIVES 
 The following were the aims and objectives of our study: 
 To study the frequency of suicidal ideation in schizophrenia.  
 To compare the clinical and socio-demographic profile of patients 
suffering from schizophrenia with and without suicidal ideation.                                                                            
 To study the various risk factors of suicidal ideation in patients 
suffering from schizophrenia. 
 To study the relationship of severity, type and duration of 
schizophrenic illness in patients with and without suicidal ideation. 
  
MATERIALS AND METHODS 
The study was carried out in the Government Kilpauk  Medical 
College, Chennai. 
STUDY DESIGN: 
Cross sectional study  
SAMPLE 
          64 consecutive patients suffering from schizophrenia based on 
ICD-10 diagnostic criteria attending the outpatient and inpatient 
department for treatment. 
STUDY: 
            A Study on suicidal ideation in schizophrenia. 
INCLUSION CRITERIA 
Patients diagnosed as suffering from schizophrenia based on the 
ICD – 10 diagnostic criteria. 
The age of patients 18 and more than 18 yrs.  
EXCLUSION CRITERIA    
Alcohol use disorder, cannabis use disorder. 
Organic condition. 
Patients who could not be evaluated by meaningful conversation 
due to sever psychosis. 
MATERIALS USED: 
Semi-structured pro-forma. 
SAPS (Scale for the assessment of positive symptoms) 
SANS (Scale for  the assessment of negative symptoms) 
CDSS (Calgary Depression rating scale for schizophrenia) 
Beck‟s Suicide intent scale. 
Scale of suicidal ideation. 
ICD-10  
A Semi-structured Pro-forma to include the socio-demographic 
data, family history, duration & type of disorder, treatment history and 
details of suicide attempt if present. 
Clinical interview used for diagnosis of schizophrenia using based 
on ICD 10 criteria.  
SAPS (Scale for the Assessment of Positive Symptoms) and SANS 
(Scale for the Assessment of Negative symptoms) were used. These 
scales were sourced from the University of Iowa Press, 1983. These 
scales are used for assessment of positive and negative symptoms, 
principally those occurring in schizophrenia. Both the instruments are 
used in a way complimentary to each other. They have been widely used 
in many studies and well tested for reliability and validity. The SAPS 
contains 35 items divided into 5 domains i.e. Hallucinations, Delusions, 
Bizarre behaviour, Positive formal thought disorder and Inappropriate 
affect. The SANS contains 24 items divided into 5 domains i.e. Affective 
flattening or blunting, alogia, avolition-apathy, anhedonia-asociality and 
Attention. Items in both the scales are score between 0 (none) and 5 
(Severe). 
CDSS: 
CDSS (The Calgary Depression rating Scale for Schizophrenia) 
was used. The CDSS had been developed by Drs. D. and J. Addington, 
belongs to the University of Calgary. This scale was used to assess the 
level of depression in schizophrenic patients differentiate from positive 
symptoms, negative symptoms and extra pyramidal symptoms. It has 
been evaluated in relapsed and remitted patients. It is an semi-structured 
observer scale. It has 9 items rated from 0 to 3.  The CDSS depression 
score was obtained by adding each of the item scores. A score above 6 
has 82% specificity and 85% sensitivity.  The scale had good construct 
validity. 
Beck‟s Suicide intent scale was applied to measure the score for 
suicide intent in the suicide victims. This scale was developed by Beck et 
al in 1974. This is a scale which assesses the objective circumstances 
related to suicide as well as self report. There are 20 items in the self-
report questionnaire.  Each item is scored between 0 and 3 with a total 
score ranging from 0 to 60.  
                 15-19 -Low intent,  
                  20-28 -Medium intent, 
                  29 - plus- High intent. 
SCALE OF SUICIDAL IDEATION:   
This scale had 19 items. It is used to assess patient suicidal 
intentions. This scale was also be used to monitor treatment response. 
Each item rated from 0 to 2.  Score ranging from 0 to 38. 
          Minimum score - 0. 
          Maximum score - 38.  
          High score indicate greater suicidal ideation. 
It has a reliability coefficient of 0.89. The interrater reliability 
coefficient was 0.83 (p < .001).  
Consecutive patients fulfilling ICD 10 criteria for schizophrenia 
were evaluated in the review OPD department of the Kilpauk Medical 
College Chennai-10 in April 2016. 64 consecutive patients fulfil the 
inclusion and exclusion criteria. The diagnosis confirmed by checked 
from case records and re-confirmed by 2 psychiatrists, one of them a 
senior one. 
 Informed consent in a written form was obtained for participation 
in the study from the patients as well as the relatives. 
           The patients were administered the Semi-structured pro-forma, 
Scale for the Assessment of Positive Symptoms (SAPS), Scale for the 
Assessment of Negative Symptoms (SANS), The Calgary Depression 
rating Scale for Schizophrenia (CDSS), Beck suicide scale and Scale for 
suicidal ideation for patients suffering from schizophrenia.  The scales 
were applied during the time of study.  
           The collected data were discussed with reference to the aims and 
objectives of the study. Statistical analysis was done using the chi-square 
test and the unpaired t-test. 
         Approval was obtained from the Ethics committee of the Kilpauk 
Medical college Chennai-10. 
  
HYPOTHESIS: 
 We assumed the following hypotheses: 
Null Hypothesis : H0  
With Suicide Ideation group equal in 
effect compared to without Suicide 
Ideation group 
Alternate Hypothesis : H1  
With Suicide Ideation group 
hazardous in effect compared to 
without Suicide Ideation group  
 
DATA ANALYSIS: 
 Descriptive statistics was done for all data and were reported in 
terms of mean values and percentages. Suitable statistical tests of 
comparison were done. Continuous variables were analysed with the 
unpaired t test.. Categorical variables were analysed with the Chi-Square 
Test and Fisher Exact Test. Statistical significance was taken as P < 0.05. 
The data was analysed using SPSS version 16 and Microsoft Excel 2007. 
  
RESULTS 
A total of 64 patients were interviewed. There are two main groups 
in our study – those with suicide ideation and those without ideation. The 
prevalence of suicide ideation in our study was 45.31% (n=29). 
Groups Number 
With Suicide Ideation 29 
Without Suicide Ideation 35 
 
ANALYSIS WITH RESPECT TO AGE: 
 
 
Age 
With Suicide 
Ideation 
Without 
Suicide 
Ideation 
With Suicide 
Ideation % 
Without 
Suicide 
Ideation % 
18-44 yrs 26 29 89.66 82.86 
45-64 yrs 3 6 10.34 17.14 
65 or 
more 
0 0 0.00 0.00 
Total 29 35 100 100 
P value 
Fishers Exact Test 
0.4441 
 
 Among the study patients, there was no statistically significant 
difference in relation to age distribution between with suicide ideation 
group (majority belonged to 18-44 years age class interval =89.66%) and 
without suicide ideation group (majority belonged to 18-44 years age 
class interval =82.86%) with a p value of <0.05 as per fishers exact test. 
Therefore we fail to reject the null hypothesis that there is no difference 
in age distribution between the study groups. 
  
 ANALYSIS WITH RESPECT TO GENDER 
 
 
 
 
 
 
 
 Gender 
With Suicide 
Ideation 
Without 
Suicide 
Ideation 
With Suicide 
Ideation % 
Without 
Suicide 
Ideation % 
Male 15 15 51.72 42.86 
Female 14 20 48.28 57.14 
Total 29 35 100 100 
P value 
Chi Squared Test 
0.6156 
 
Among the study patients, there was no statistically significant 
difference in relation to gender status between with suicide ideation group 
(majority belonged to male gender =51.72%) and without suicide ideation 
group (majority belonged to female gender =57.14%) with a p value of 
<0.05 as per chi squared test. Therefore we fail to reject the null 
hypothesis that there is no difference in gender status between the study 
groups. 
  
  
EDUCATIONAL STATUS 
 
  
Education
al Status 
With 
Suicide 
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation 
% 
Without 
Suicide 
Ideation 
% 
P value 
Fishers 
Exact 
Test 
Illiterate 2 1 6.90 2.86 0.8589 
Primary 1 2 3.45 5.71 .0.9999 
Secondary 1 3 3.45 8.57 0.6198 
SSC 7 5 24.14 14.29 0.3519 
HSC 8 23 27.59 65.71 0.0029* 
Graduate 10 1 34.48 2.86 0.0016* 
Total 29 35 100 100  
 
Among the study patients, there was a statistically significant 
difference in relation to educational status (HSC and Graduates) between 
with suicide ideation group (majority were graduates = 34.48%) and 
without suicide ideation group (majority were HSC passed =65.71%) 
with a p value of <0.05 as per fishers exact test. Therefore we reject the 
null hypothesis that there is no difference in educational status (HSC and 
Graduates) between the study groups. 
  
 OCCUPATIONAL STATUS 
 
 
  
Occupational Status 
With 
Suicide 
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation 
% 
Without 
Suicide 
Ideation 
% 
Unemployed 20 20 68.97 57.14 
Unskilled 0 2 0.00 5.71 
Semiskilled 4 7 13.79 20.00 
Skilled 1 0 3.45 0.00 
Clerical, Shop owner, 
Farmer 
3 4 10.34 11.43 
Semi-professional 0 2 0.00 5.71 
Professional 1 0 3.45 0.00 
Total 29 35 100 100 
P value 
Chi Squared Test 
0.4582 
 
Among the study patients, there was no statistically significant 
difference in relation to occupational status between with suicide ideation 
group (majority were unemployed =69.87%) and without suicide ideation 
group (majority were unemployed =57.14%) with a p value of <0.05 as 
per chi squared test. Therefore we fail to reject the null hypothesis that 
there is no difference in occupational status between the study groups. 
 
 SOCIOECONOMIC STATUS 
 
 
 
 
 
Socioeconomic With Without With Without 
Status Suicide 
Ideation 
Suicide 
Ideation 
Suicide 
Ideation % 
Suicide 
Ideation % 
Upper 0 0 0.00 0.00 
Middle Upper 1 0 3.45 0.00 
Lower Middle 3 1 10.34 2.86 
Upper Lower 25 34 86.21 97.14 
Lower 0 0 0.00 0.00 
Total 29 35 100 100 
P value 
Chi Squared Test 
0.2070 
 
Among the study patients, there was no statistically significant 
difference in relation to socioeconomic status between with suicide 
ideation group (majority were upper lower class =86.21%) and without 
suicide ideation group (majority were upper lower class =97.14%) with a 
p value of <0.05 as per chi squared test. Therefore we fail to reject the 
null hypothesis that there is no difference in socioeconomic status 
between the study groups. 
 
 
 MARITAL STATUS 
 
 
 
 
 
 
Marital With Without With Without 
Status Suicide 
Ideation 
Suicide 
Ideation 
Suicide 
Ideation % 
Suicide 
Ideation % 
Married 14 21 48.28 60.00 
Unmarried 15 13 51.72 37.14 
Separated 0 0 0.00 0.00 
Divorced 0 0 0.00 0.00 
Widowed 0 1 0.00 2.86 
Total 29 35 100 100 
P value 
Chi Squared Test 
0.3135 
 
Among the study patients, there was no statistically significant 
difference in relation to marital status between with suicide ideation 
group (majority were unmarried =51.72%) and without suicide ideation 
group (majority were married = 60.00%) with a p value of >0.05 as per 
chi squared test. Therefore we fail to reject the null hypothesis that there 
is no difference in marital status between the study groups. 
  
  
TYPE OF FAMILY 
 
 
 
 
 
 
Type of 
Family 
With 
Suicide 
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation 
% 
Without 
Suicide 
Ideation 
% 
P value 
Fishers 
Exact Test 
Nuclear 13 4 44.83 11.43 0.0041* 
Joint 16 31 55.17 88.57 0.0043* 
Extended 0 0 0.00 0.00 NA 
Broken 0 0 0.00 0.00 NA 
Total 29 35 100 100  
 
Among the study patients, there was a statistically significant 
difference in relation to type of family status (nuclear and joint) between 
with suicide ideation group (majority belonged to nuclear family = 
44.83%) and without suicide ideation group (majority belonged to joint 
family = 88.57%) with a p value of <0.05 as per fishers exact test. 
Therefore we reject the null hypothesis that there is no difference in type 
of family status (nuclear and joint) between the study groups. 
  
  
FAMILY HISTORY OF MENTAL ILLNESS 
 
 
 
 
 
Family 
History of 
Mental 
Illness 
With 
Suicide 
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation % 
Without 
Suicide 
Ideation % 
Present 11 0 37.93 0.00 
Absent 18 35 62.07 100.00 
Total 29 35 100 100 
P value 
Fishers Exact Test 
<0.0001* 
 
Among the study patients, there was a statistically significant 
difference in relation to family history of mental illness status between 
with suicide ideation group (majority had negative history = 62.07%) and 
without suicide ideation group (majority had negative history = 100.00%) 
with a p value of <0.05 as per fishers exact test. Therefore we reject the 
null hypothesis that there is no difference in family history of mental 
illness status between the study groups. 
  
  
FAMILY HISTORY OF SUICIDE ATTEMPT 
 
 
 
 
 
 
 
 Family 
History of 
Suicide 
Attempt 
With 
Suicide 
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation % 
Without 
Suicide 
Ideation % 
Present 6 1 20.69 2.86 
Absent 23 34 79.31 97.14 
Total 29 35 100 100 
P value 
Fishers Exact Test 
0.0401* 
 
Among the study patients, there was a statistically significant 
difference in relation to family history of suicide attempt status between 
with suicide ideation group (majority had negative history = 79.31%) and 
without suicide ideation group (majority had negative history = 97.14%) 
with a p value of <0.05 as per fishers exact test. Therefore we reject the 
null hypothesis that there is no difference in family history of suicide 
attempt status between the study groups. 
  
  
DURATION OF ILLNESS 
 
 
 
 
 
 
 Duration of 
Illness 
With 
Suicide –
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation % 
Without 
Suicide 
Ideation % 
.< 1 year 0 1 0.00 2.86 
1-2 years 2 8 6.90 22.86 
2-5 years 19 16 65.52 45.71 
> 5 years 8 10 27.59 28.57 
Total 29 35 100 100 
P value 
Fishers Exact Test 
0.1683 
 
Among the study patients, there was no statistically significant 
difference in relation to duration of illness between with suicide ideation 
group (majority were 2-5 years =65.52%) and without suicide ideation 
group (majority were 2-5 years = 45.71%) with a p value of >0.05 as per 
fishers exact test. Therefore we fail to reject the null hypothesis that there 
is no difference in duration of illness between the study groups. 
 
 
  
WHETHER ON TREATMENT 
 
 
 
 
 
 
 
 On 
Treatment 
With 
Suicide 
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation % 
Without 
Suicide 
Ideation % 
Yes 28 35 96.55 100.00 
No 1 0 3.45 0.00 
Total 29 35 100 100 
P value 
Fishers Exact Test 
0.4531 
 
Among the study patients, there was no statistically significant 
difference in relation to on treatment status between with suicide ideation 
group (majority were on treatment =96.55%) and without suicide ideation 
group (majority on treatment = 100.00%) with a p value of >0.05 as per 
fishers exact test. Therefore we fail to reject the null hypothesis that there 
is no difference in on treatment status between the study groups. 
 
  
  
HISTORY OF SUICIDE ATTEMPTS 
 
 
 
 
 
 
 History of 
Suicide 
Attempts 
With 
Suicide 
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation % 
Without 
Suicide 
Ideation % 
Yes 2 1 6.90 2.86 
No 27 34 93.10 97.14 
Total 29 35 100 100 
P value 
Fishers Exact Test 
0.5859 
 
Among the study patients, there was no statistically significant 
difference in relation to history of suicide attempts between with suicide 
ideation group (majority had no history =93.10%) and without suicide 
ideation group (majority had no history = 97.14%) with a p value of 
>0.05 as per fishers exact test. Therefore we fail to reject the null 
hypothesis that there is no difference in history of suicide attempts 
between the study groups. 
  
  
HISTORY OF HOSPITALISATION AFTER SUICIDE ATTEMPTS 
 
 
 
 
 
 
 
 History of 
hospitalisat
ion After 
Suicide 
Attempts 
With 
Suicide 
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation % 
Without 
Suicide 
Ideation % 
Yes 2 1 6.90 2.86 
No 27 34 93.10 97.14 
Total 29 35 100 100 
P value 
Fishers Exact Test 
0.5859 
 
Among the study patients, there was no statistically significant 
difference in relation to history hospitalization after suicide attempts 
between with suicide ideation group (majority had no history =93.10%) 
and without suicide ideation group (majority had no history = 97.14%) 
with a p value of >0.05 as per fishers exact test. Therefore we fail to 
reject the null hypothesis that there is no difference in history of 
hospitalization after suicide attempts between the study groups. 
 
 
  
REASON FOR ATTEMPT 
 
 
 
 
 
 
  
Reason for 
Attempt 
With 
Suicide 
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation 
% 
Without 
Suicide 
Ideation 
% 
P value 
Fishers 
Exact 
Test 
Secondary to 
Delusions 
0 0 0.00 0.00 NA 
Hallucinations 0 1 0.00 2.86 0.4531 
Depressive 
Features 
2 0 6.90 0.00 0.2014 
Insight/ 
Impulsive 
0 0 0.00 0.00 NA 
No Attempt 27 34 93.10 97.14  
Total 29 35 100 100  
 
  
 Among the study patients, there was no statistically significant 
difference in relation to reason for attempt between with suicide ideation 
group (majority had depressive features =6.90%) and without suicide 
ideation group (majority had hallucinations = 2.86%) with a p value of 
>0.05 as per fishers exact test. Therefore we fail to reject the null 
hypothesis that there is no difference in reason for attempt between the 
study groups. 
  
  
MODE OF ATTEMPT 
 
 
  
  
Mode of 
Attempt 
With 
Suicide 
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation 
% 
Without 
Suicide 
Ideation 
% 
P value 
Fishers 
Exact 
Test 
Overdose 1 1 3.45 2.86 >0.9999 
OPC 0 0 0.00 0.00 NA 
Other 
Poisoning 
0 0 0.00 0.00 NA 
Hanging 1 0 3.45 0.00 0.4531 
Drowning 0 0 0.00 0.00 NA 
Others 0 0 0.00 0.00 NA 
No attempt 27 34 93.10 97.14  
Total 29 35 100 100  
 
  
  
Among the study patients, there was no statistically significant 
difference in relation to mode of attempt between with suicide ideation 
group (majority had overdose and hanging =3.45%) and without suicide 
ideation group (majority had overdose= 2.86%) with a p value of >0.05 
as per fishers exact test. Therefore we fail to reject the null hypothesis 
that there is no difference in mode of attempt between the study groups. 
 
  
  
COMMUNICATION OF ATTEMPT 
 
 
 
 
 
 
 Communication 
of Attempt 
With 
Suicide 
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation % 
Without 
Suicide 
Ideation % 
Yes 0 0 0.00 0.00 
No 2 1 6.90 2.86 
No Attempt 27 34 93.10 97.14 
Total 29 35 100 100 
P value 
Fishers Exact Test 
0.5859 
 
Among the study patients, there was no statistically significant 
difference in relation to communication of attempt between with suicide 
ideation group (majority had not communicated =6.90%) and without 
suicide ideation group (majority had not communicated= 2.86%) with a p 
value of >0.05 as per fishers exact test. Therefore we fail to reject the null 
hypothesis that there is no difference in communication of attempt 
between the study groups. 
 
 
  
REASON FOR IDEATION 
 
 
 
 
 
 
 
 Reason For 
Ideation 
With 
Suicide 
Ideation 
Without 
Suicide 
Ideation 
With 
Suicide 
Ideation % 
Without 
Suicide 
Ideation % 
Secondary 
to Delusion 
10 0 34.48 0.00 
Secondary 
to 
Hallucinatio
ns 
6 0 20.69 0.00 
Secondary 
to 
Depression 
12 0 41.38 0.00 
Secondary 
to Delusion 
1 0 3.45 0.00 
No attempt 0 35 0.00 100.00 
Total 29 35 100 100 
P value 
Chi Squared Test 
>0.9999 
 
  
Among the study patients, there was no statistically significant 
difference in relation to reason for ideation between with suicide ideation 
group (majority was secondary to depression =41.38%) and without 
suicide ideation group (majority had no ideation= 100.00%) with a p 
value of >0.05 as per fishers exact test. Therefore we fail to reject the null 
hypothesis that there is no difference in reason for ideation between the 
study groups. 
  
  
SCORING IN STUDY SUBJECTS 
 
 
 
  
 Scoring in Study Subjects 
SAPS 
Score 
SAN
S 
Score 
CDS
S 
Score 
Beck'
s 
Score 
Scale 
of 
Suici
dal 
Ideati
on. 
With 
Suicide 
Ideation 
N 29 29 29 2 26 
Mean 123.10 84.00 12.00 14.00 27.88 
SD 19.32 16.38 4.28 2.83 2.45 
Without 
Suicide 
Ideation 
N 35 35 35 1 1 
Mean 80.86 41.91 3.49 14.00 24.00 
SD 14.72 15.39 2.99 NA NA 
P value 
Unpaired t Test 
<0.0001 
<0.00
01 
<0.00
01 
NA NA 
 
  
SAPS 
Among the study patients, there was a statistically significant 
difference in relation to SAPS scores between with suicide ideation group 
(mean = 123.10, SD = 19.32) and without suicide ideation (mean = 80.86, 
SD = 14.72) with a p value of <0.05 as per unpaired t test. Therefore we 
reject the null hypothesis that there is no difference in SAPS score 
distribution between the study groups. 
SANS 
Among the study patients, there was a statistically significant 
difference in relation to SANS scores between with suicide ideation 
group (mean = 84.00, SD = 16.38) and without suicide ideation (mean = 
41.91, SD = 15.39) with a p value of <0.05 as per unpaired t test. 
Therefore we reject the null hypothesis that there is no difference in 
SANS score distribution between the study groups. 
CDSS 
Among the study patients, there was a statistically significant 
difference in relation to CDSS scores between with suicide ideation group 
(mean = 12.00, SD = 4.28) and without suicide ideation (mean = 3.49, SD 
= 2.99) with a p value of <0.05 as per unpaired t test. Therefore we reject 
the null hypothesis that there is no difference in CDSS score distribution 
between the study groups. 
  
DISCUSSION 
EDUCATIONAL STATUS: 
Low educational status schizophrenic patients are having high risk 
of suicide.(Mitchael G Gelder et al) 
The incidence of study subjects with HSC educational status was 
significantly less in with suicide ideation group compared to without 
suicide ideation group by a percentage difference of 31.13% (58% lower). 
This difference is significant with a p-value of 0.0029 as per fishers exact 
test.  
The incidence of study subjects with graduate educational status 
was significantly more in with suicide ideation group compared to 
without suicide ideation group by a percentage difference of 31.63% 
(92% higher). This difference is significant with a p-value of 0.0016 as 
per fishers exact test.  
TYPE OF FAMILY: 
In living with nuclear type family schizophrenic patients are having 
high suicidal risk than living with joint type family schizophrenic 
patients.(Mitcheal G Geider et al) 
The incidence of study subjects with nuclear family status was 
significantly more in with suicide ideation group compared to without 
suicide ideation group by a percentage difference of 33.40% (75% 
higher). This difference is significant with a p-value of 0.0041 as per 
fishers test.  
The incidence of study subjects with joint family status was 
significantly less in with suicide ideation group compared to without 
suicide ideation group by a percentage difference of 33.40% (38% lower). 
This difference is significant with a p-value of 0.0043 as per fishers test.  
FAMILY H/O MENTAL ILLNESS: 
Family history of mental illness, associated schizophrenic patients 
are having higher risk of suicide. (Mitcheal G Geider et al) 
The incidence of study subjects with family history of mental 
illness was significantly more in with suicide ideation group compared to 
without suicide ideation group by a percentage difference of 37.93% 
(62% higher). This difference is significant with a p-value of <0.0001 as 
per fishers test.  
  
FAMILY HISTORY OF SUICIDE ATTEMPT: 
Family history of suicide attempts, schizophrenic patients are 
having higher risk of suicide. (Mitcheal G Geider et al) 
The incidence of study subjects with family history of suicide 
attempt was significantly more in with suicide ideation group compared 
to without suicide ideation group by a percentage difference of 17.83% 
(86% higher). This difference is significant with a p-value of 0.0401 as 
per fishers exact test.  
Scoring in Study Subjects 
SAPS 
Schizophrenic suicide victims differ from other schizophrenic 
patients by having suicidal thoughts and previous suicide attempts, being 
more depressive and having more positive symptoms. (Kelly et al)  
The mean SAPS scores was significantly more with suicide 
ideation group compared to without suicide ideation group by a mean 
difference of 42.25 points (34% higher). This difference is significant 
with a p-value of <0.0001 as per unpaired t test.  
  
SANS 
The mean SANS scores was significantly more with suicide 
ideation group compared to without suicide ideation group by a mean 
difference of 42.09 points (50% higher). This difference is significant 
with a p-value of <0.0001 as per unpaired t test.  
CDSS 
Suicide risk is highest in depressive in patients even during the post 
discharge period and much lower among psychiatric outpatients, although 
clearly lowest for those treated for depression in primary care.(Simon, 
G.E. et al )   
The mean CDSS scores was significantly more with suicide 
ideation group compared to without suicide ideation group by a mean 
difference of 8.51 points (71% higher). This difference is significant with 
a p-value of <0.0001 as per unpaired- t test. 
  
CONCLUSION 
In this study we can safely conclude that a significantly decreased 
HSC educational status and increased graduate educational status is 
associated with suicide ideation group compared to without suicide 
ideation group in patients with schizophrenia. In other words in patients 
with schizophrenia those with HSC education are 2.38 times more 
common to develop suicide ideation and those with graduate education 
are 12.07 times less common to develop suicide ideation. So in patients 
with schizophrenia nuclear school education is a significant risk factor 
and college education is a significant protective factor for suicides.  
In this study we can safely conclude that a significantly increased 
nuclear family status and decreased joint family status is associated with 
suicide ideation group compared to without suicide ideation group in 
patients with schizophrenia. In other words in patients with schizophrenia 
those from nuclear families are 3.92 times more common to develop 
suicide ideation and those from joint families are 1.61 times less common 
to develop suicide ideation. 
In this study we can safely conclude that a significantly increased 
family history of mental illness status is associated with suicide ideation 
group compared to without suicide ideation group in patients with 
schizophrenia. In other words in patients with schizophrenia those with 
family history of mental illness are 1.61 times more prone to develop 
suicide ideation. So in patients with schizophrenia family history of 
mental illness is a significant risk factor for suicides.  
In this study we can safely conclude that a significantly increased 
family history of suicide attempt status is associated with suicide ideation 
group compared to without suicide ideation group in patients with 
schizophrenia. In other words in patients with schizophrenia those with 
family history of suicide attempt are 7.24 times more prone to develop 
suicide ideation. So in patients with schizophrenia family history of 
suicide attempt is a significant risk factor for suicides.  
In this study we can safely conclude that a significantly increased 
SAPS scores is associated with suicide ideation group compared to 
without suicide ideation group in patients with schizophrenia. In other 
words in patients with schizophrenia those with increased SAPS scores 
are 1.52 times more prone to develop suicide ideation. So in patients with 
schizophrenia increased SAPS score is a significant risk factor for 
suicides.  
In this study we can safely conclude that a significantly increased 
SANS scores is associated with suicide ideation group compared to 
without suicide ideation group in patients with schizophrenia. In other 
words in patients with schizophrenia those with increased SANS scores 
are 2.00 times more prone to develop suicide ideation. So in patients with 
schizophrenia increased SANS score is a significant risk factor for 
suicides.  
In this study we can safely conclude that a significantly increased 
CDSS scores is associated with suicide ideation group compared to 
without suicide ideation group in patients with schizophrenia. In other 
words in patients with schizophrenia those with increased CDSS scores 
are 3.44 times more prone to develop suicide ideation. So in patients with 
schizophrenia increased CDSS score is a significant risk factor for 
suicides. 
LIMITATIONS: 
Low sample size. So little space for robust statistical analysis. 
Study population restricted to patients referred to our psychiatric 
department. 
Selection bias may have influenced the results. 
This study not included less than 18 years old patients, less than 18 
years old patients are not represented.  
It is a cross sectional study, follow up study may provide more 
information regarding longitudinal course.   
Poor financial support. 
Inability to use research design like cohort study due to paucity of 
time and resources. 
People from upper socio economic status have not been 
represented in this study. In our study most of the patients are belongs to 
lower and lower middle socio-economic status. 
Alcohol and cannabis abuse not included. That may have bias in 
the result. 
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PROFORMA 
Name: 
Age: 
Sex: 
Education: Illiterate/ Primary/ Secondary/ SSC/ HSC/ Graduate 
Occupation: Unemployed/ Unskilled/ Skilled/ Housewife/ Student 
Socio-economic status: Low/ Middle/ High 
Marital status: Married/ Unmarried/ Separated/ Divorced 
Type of family: Nuclear/ Joint 
Family history: Mental illness/ Suicide/ Both 
Diagnosis: Paranoid/ Catatonic/ Undifferentiated/ Disorganized/ Other 
Duration of illness: < 1 year/ 1-2 years/ 2-5 years/ > 5 years. In months: 
Medication details: 
Past attempts of suicide: Yes/ No; If yes, details 
History of hospitalization for the attempt: Yes/ No; If yes, details 
Reason for attempting: Secondary to delusions/ Hallucinations/ 
Depressive features/ 
Insight/ Impulsive 
Mode of attempt: Overdose/ OPC or other poisoning/ Hanging/ 
Drowning/ Others 
Communication of attempt: Yes/ No; If yes details 
INFORMED CONSENT FORM 
STUDY: “A STUDY ON SUICIDAL IDEATION IN   
  SCHIZOPHRENIA” 
STUDY CENTRE: Department of Psychiatry, Govt. Kilpauk Medical 
College Hospital. 
PATIENT’S NAME : 
PATIENT’S AGE : 
I.P NO.   : 
Patient may check ( ) these boxes 
I confirm that I understood the purpose of the procedure for the above 
study.          ( ) 
I had the opportunity to ask question and all my questions and doubts 
have been answered to my complete satisfaction.   ( ) 
I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time without giving reason, without my legal 
rights being affected.       ( ) 
I understand that an ethical committee members  and the regulatory 
authorities will not need my permission to look at my health records, both 
in respect of the current study and any further research that may be 
conducted in relation to it, even if I withdraw from the study I agree to 
this access.           ( ) 
However, I understand that my identity will not be revealed in any 
information released to third parties or published, unless as required 
under the law.         ( ) 
I agree not to restrict the use of any data or results that arise from the 
study.          ( ) 
I agree to take part in the above study and to comply with the instructions 
given during the study and faithfully co-operate with the study team and 
to immediately inform the study staff if I suffer from any deterioration in 
my health or well being or any unexpected or unusual symptoms.( ) 
I hereby consent to participate in this study.    ( ) 
I hereby give permission to undergo complete clinical examination and 
diagnostic tests including haematological, biochemical, radiological tests. 
           ( ) 
 
Signature / thumb impression 
Patient‟s name and address: 
 
 
Place: 
Date: 
 
 
Signature of the investigator: 
Study investigator‟s name: 
Place: 
Date: 
PARTICIPANTS' INFORMATION SHEET 
 
Investigator   : Dr.A.KUMARESAN 
Name of the participant :  
 
Study title:  “A Study on suicidal ideation in schizophrenia” 
 
 You are invited to take part in this research study. We have 
got approval from the IEC. You are asked to participate because 
you satisfy the eligibility criteria. 
 
What is the purpose of this research? 
 In this study, we aim to assess the prevalence of suicidal 
ideation in people undergoing treatment for schizophrenia, the 
association between psychiatric co-morbidity and different 
socio-demographic factors (age, gender, education) and disease 
related factors. This will help in assessing the burden of suicidal 
ideation in people with schizophrenia and how it affects the 
outcome of schizophrenia, so that earlier detection and 
management may improve the outcome of schizophrenia. 
Benefits: 
 This study will benefit all people who are undergoing 
treatment for schizophrenia and help improve the success rate of 
schizophrenic treatment, and also reduce the incidence of 
suicidal ideation in schizophrenia. 
Discomforts and risks: 
 No interventional procedure is done in this study. 
Confidentiality: 
 Patients who participate in the study and their details will 
be maintained confidentially and at any cost, those details will 
not be let out. 
 
Right to withdraw: 
Patients will not be forced to complete the study. At any cost, in 
such circumstances treatment will not be compromised. 
 
 
 
Signature/Thumb impression of the participant: 
 
 
Signature of the investigator: 
 
Date : 
Place : 
சு஬ ஒப்புதல் படிவம் 
ஆய்வு செய்஬ப்படும் தலயப்பு: 
"காெந ாய் உள்ரவர்கரிடம் இருக்கும் ஫னந ாய்கலரக் 
குமித்த ஆ஭ாய்ச்ெி.” 
ஆ஭ாய்ச்ெி  ிலய஬ம் : நெஞ்சகத் துறறப் பிரிவு , கீழ்ப்பாக்கம் 
மருத்துவக்கல்லூரி அரசு மருத்துவமறை, நசன்றை. 
 
பங்கு சபறுபவரின் சப஬ர்: 
உமவு முலம: 
பங்கு சபறுபவரின் எண்: 
பங்கு சபறுபவர் இதலன ( ) குமிக்கவும் 
மமமல குறிப்பிட்டுள்ள மருத்துவ ஆய்வின் விவரங்கள் எைக்கு 
விளக்கப்பட்டது. என்னுறடய சந்மேகங்கறளக் மகட்கவும் , 
அேற்காை ேகுந்ே விளக்கங்கறளப் நபறவும் 
வாய்ப்பளிக்கப்பட்டது.  ( ) 
ொன் இவ்வாய்வில் ேன்ைிச்றசயாகத்ோன் பங்மகற்கிமறன் . 
எந்ேக் காரணத்ேிைாமலா எந்ேக் கட்டத்ேிலும் எந்ே சட்ட 
சிக்கலுக்கும் உட்படாமல் ொன் இவ்வாய்வில் இருந்து விலகிக் 
நகாள்ளலாம் என்றும் அறிந்து நகாண்மடன்.    
     ( ) 
இந்ே ஆய்வு சம்மந்ேமாகவும் , மமலும் இது சார்ந்ே ஆய்வு 
மமற்நகாள்ல௃ம்மபாதும், இந்ே ஆய்வில் பங்குநபறும் 
மருத்துவர் என்னுறடய மருத்துவ அறிக்றககறளப் 
பார்ப்பேற்கு என் அனுமேி மேறவயில்றல எை 
அறிந்துநகாள்கிமறன். ொன் ஆய்வில் இருந்து விலகிக் 
நகாண்டாலும் இது நபாருந்தும் எை அறிகிமறன்.  ( ) 
இந்ே ஆய்வின் மூலம் கிறடக்கும் ேகவல்கறளம௃ம் , 
பரிமசாேறை முடிவுகறளம௃ம் மற்றும் சிகிச்றச நோடர்பாை 
ேகவல்கறளம௃ம் மருத்துவர் மமற்நகாள்ல௃ம் ஆய்வில் 
பயன்படுத்ேிக் நகாள்ளவும் , அறேப் பிரசுரிக்கவும் என் முழு 
மைதுடன் சம்மேிக்கிமறன்.   ( ) 
இந்ே ஆய்வில் பங்கு நகாள்ள ஒப்புக்நகாள்கிமறன் . எைக்குக் 
நகாடுக்கப்பட்ட அறிவுறரகளின் படி ெடந்துநகாள்வதுடன் , இந்ே 
ஆய்றவ மமற்நகாள்ல௃ம் மருத்துவ அணிக்கு உண்றமம௃டன் 
இருப்மபன் என்றும் உறுேியளிக்கிமறன் . என் உடல் ெலம் 
பாேிக்கப்பட்டாமலா அல்லது எேிர்பாராே வழக்கத்ேிற்கு மாறாக 
மொய்க்குறி நேன்பட்டாமலா உடமை அறே மருத்துவ 
அணியிடம் நேரிவிப்மபன் எை உறுேி அளிக்கிமறன். ( ) 
இந்ே ஆய்வில் எைக்கு மருத்துவப் பரிமசாேறை நசய்து 
நகாள்ள மற்றும் ஆய்வில் பங்மகற்க ொன் முழு மைதுடன் 
சம்மேிக்கிமறன்.        ( ) 
பங்மகற்பவரின் றகநயாப்பம் / கட்றடவிரல் மரறக:  
 
___________________ 
இடம்: ____________________________ 
மேேி: _____________________________ 
பங்மகற்பவரின் நபயர் மற்றும் விலாசம்:: 
 
ஆய்வாளரின் றகநயாப்பம் _________________________ 
இடம் _________________________ 
மேேி __________________________ 
ஆய்வாளரின் நபயர் ____________________________
 ஆ஭ாய்ச்ெி தகவல் தாள் 
 
 
 கிழ்பாக்கம் அரசு நபாது மருத்துவமறையில் காசமொய் 
உள்ளவர்களிடம் இருக்கும் மைமொய்கறளக் குறித்து 
ஆராய்ச்சி நசய்ய உள்மளாம் .  ெீங்கள் இந்ே ஆராய்ச்சியில் 
பங்மகற்க ொங்கள் விரும்புகிமறாம் . இந்ே ஆராய்ச்சியில் 
பங்மகற்போல் ேங்களது மொயின் ஆய்வறிக்றகமயா அல்லது 
சிகிச்றசமயா பாேிக்கப்படாது என்பறேம௃ம் நேரிவித்துக் 
நகாள்கிமறாம். 
 
 இந்ே ஆராய்ச்சியின் முடிவுகறள அல்லது கருத்துகறள 
நவளியிடும் மபாமோ அல்லது ஆராய்ச்சியின் மபாமோ 
ேங்களது நபயறரமயா அல்லது அறடயாளங்கறளமயா 
நவளியிடமாட்மடாம் என்பறேம௃ம் நேரிவித்துக் நகாள்கிமறாம். 
  
 இந்ே ஆராய்ச்சியில் பங்மகற்பது ேங்கல௃றடய 
விருப்பத்ேின் மபரில் ோன் இருக்கிறது . மமலும் ெீங்கள் 
எந்மெரமும் இந்ே ஆராய்ச்சியில் இருந்து பின்வாங்கலாம் 
என்பறேம௃ம் நேரிவித்துக்நகாள்கிமறாம். 
 
 இந்ே சிறப்புப் பரிமசாேறைகளின் முடிவுகறள 
ஆராய்ச்சியின் மபாமோ அல்லது ஆராய்ச்சியின் முடிவின் 
மபாமோ ேங்கல௃க்கு அறிவிப்மபாம் என்பறேம௃ம் 
நேரிவித்துக்மகாள்கிமறாம்.  
 
 
 
 
ஆராய்ச்சியாளர் றகநயாப்பம் பங்மகற்பாளர் றகநயாப்பம் 
 
 KUPPUSWAMY’S SOCIOECONOMIC STATUS SCALE 
(A) EDUCATION SCORE 
Profession or Honours 7 
Graduate or post graduate 6 
Intermediate or post high school diploma 5 
High school certificate 4 
Middle school certificate 3 
Primary school certificate 2 
Illiterate 1 
(B) OCCUPATION SCORE 
Profession 10 
Semi-Profession 6 
Clerical, Shop-owner, Farmer 5 
Skilled worker 4 
Semi-skilled worker 3 
Unskilled worker 2 
Unemployed 1 
(C) MONTHLY FAMILY INCOME  (Modified for 
2012) 
SCORE 
≥32050 12 
16020 – 32049 10 
12020 – 16019 6 
8010 – 12019 4 
4810 – 8009 3 
1601 – 4809 2 
 ≤ 1600 1 
 Total Score - Socioeconomic class 
26-29 - Upper (I) 
16-25 - Upper Middle (II) 
11-15 - Middle/Lower middle (III) 
5-10 - Lower/Upper lower (IV) 
<5 - Lower (V)
 Beck’s Suicide Intent Scale (1974) 
 
1. Isolation 
1.  Somebody present 
2.  Somebody nearby, or in visual or vocal contact 
3. No one nearby or in visual or vocal contact 
 
2. Timing 
1.  Intervention is probable 
2.  Intervention is not likely 
3.  Intervention is highly unlikely 
 
3. Precautions against discovery/intervention 
1. No precautions 
2. Passive precautions (as avoiding other but doing nothing to  
  prevent their intervention; alone in room with unlocked door) 
3. Active precautions (as locked door) 
 
4. Acting to get help during/after attempt 
 
1. Notified potential helper regarding attempt 
2. Contacted but did not specifically notify potential helper  
  regarding attempt 
3. Did not contact or notify potential helper 
 
5. Final acts in anticipation of death (will, gifts, insurance) 
 1. None 
 2. Thought about or made some arrangements 
 3.  Made definite plans or completed arrangements 
 
6. Active preparation for attempt 
 1. None 
 2. Minimal to moderate 
 3. Extensive 
 
7. Suicide Note 
 1. Absence of note 
2. Note written, but torn up; note thought about 
3. Presence of note 
 
8. Overt communication of intent before the attempt 
1. None 
2. Equivocal communication 
3. Unequivocal communication 
 
 9. Alleged purpose of attempt 
1. To manipulate environment, get attention, get revenge 
2. Components of above and below 
3. To escape, surcease, solve problems 
 
10. Expectations of fatality 
1. Thought that death was unlikely 
2. Thought that death was possible but not probable 
3. Thought that death was probable or certain 
 
11. Conception of method's lethality 
1. Do less to self than s/he thought would be lethal 
2. Was not sure if what s/he did would be lethal 
3. Equalised or exceeded what s/he thought would be lethal 
 
12. Seriousness of attempt 
1. Did no seriously attempt to end life 
2. Uncertain about seriousness to end life 
3. Seriously attempted to end life 
 
13. Attitude toward living/dying 
1. Did not want to die 
2. Components of above and below 
3. Wanted to die 
 
14. Conception of medical rescuability 
1. Thought that death would be unlikely if he received medical  
  attention 
2. Was uncertain whether death could be averted by medical  
  attention 
3. Was certain of death even if he received medical attention 
 
15. Degree of premeditation 
1. None; impulsive 
2. Suicide contemplated for three hours of less prior to attempt 
3. Suicide contemplated for more than three hours prior to attempt 
  Other Aspects (Not included in total score) 
 
16. Reaction to attempt 
1. Sorry it was made; feels foolish; ashamed 
2. Accepts both attempt and failure Beck‟s Suicide Intent Scale  
  (1974) 
3. Regrets failure of attempt 
 
  
 17. Visualization of death 
 1. Life after death, reunion with descendants 
2. Never-ending sleep, darkness, end of things 
3. No conceptions of or thoughts about death 
 
18. Number of previous attempts 
1. None 
2. One or two 
3. Three or more 
 
19. Relationship between alcohol intake and attempt 
1. Some alcohol intake prior to but not related to attempt; reportedly 
not enough to Impair judgment, reality testing 
2. Enough alcohol intake to impair judgment; reality testing and 
diminish responsibility 
3. Intentional intake of alcohol in order to facilitate implementation of 
attempt 
 
20. Relationship between drug intake and attempt 
1. Some drug intake prior to but not related to attempt; reportedly 
not enough to Impair judgment, reality testing 
2. Enough drug intake to impair judgment; reality testing and 
diminish the responsibility 
3. Intentional intake of drug in order to facilitate implementation of 
attempt 
 
15-19 Low Intent 
20-28 Medium Intent 
 29+- High Intent 
 
There is also a greater risk of repeated attempts the higher the intent rating. 
 CALGARY DEPRESSION RATING SCALE FOR 
SCHIZOPHRENIA; 
 
Interviewer: Ask the first question as written. Use follow up probes or 
qualifiers at your discretion. Time frame 
Refer to last two weeks unless stipulated. N.B. The last item, #9, is based on 
observations of the entire interview. 
 
1. DEPRESSION : How would you describe your mood over the last two 
weeks?  Do you keep reasonably cheerful or have you been very 
depressed or low spirited recently? In the last two weeks how often have 
you (own words) every day? All day? 
 
0. Absent Expresses some sadness or discouragement on questioning. 
1. Mild Distinct depressed mood persisting up to half the time over last 
2. Moderate 2 weeks: present daily. 
3. Severe Markedly depressed mood persisting daily over half the time     
    interferring with normal motor and social functioning. 
 
2. HOPELESSNESS : How do you see the future for yourself? Can you 
See  any future? - or has life seemed quite hopeless? Have you given 
up or does there still seem some reason for trying? 
 
0. Absent 
1. Mild Has at times felt hopeless over the last two weeks but still has 
     Some  degree of hope for the future. 
2. Moderate Persistent, moderate sense of hopelessness over last week. 
    Can be persuaded to acknowledge possibility of things being better. 
3. Severe Persisting and distressing sense of hopelessness. 
 
3. SELF DEPRECIATION : What is your opinion of  yourself compared 
 to other people? Do you feel better, not as good, or about the same as 
 others? Do you feel inferior or even worthless?  
 
0. Absent  
1. Mild Some inferiority; not amounting to feeling of worthlessness. 
2. Moderate Subject feels worthless, but less than 50% of the time. 
3. Severe Subject feels worthless more than 50% of the time. May be 
    Challenge  to acknowledge otherwise. 
 
4. GUILTY IDEAS OF REFERENCE : Do you have the feeling that you 
are  being  blamed for something or even wrongly accused? What 
about? (Do not include justifiable blame or accusation. Exclude 
delusions of guilt.) 
0. Absent  
 1. Mild Subject feels blamed but not accused less than 50% of the time. 
2. Moderate Persisting sense of being blamed, and/or occasional sense 
    of being accused. 
3. Severe Persistent sense of being accused. When challenged,  
    acknowledges that it is not so. 
 
5. PATHOLOGICAL  GUILT : Do you tend to blame yourself for little 
things  you may have done in the past? Do you think that you deserve 
to be so concerned about this? 
0. Absent 
1. Mild Subject sometimes feels over guilty about some minor 
    peccadillo, but less than 50% of time. 
2. Moderate Subject usually (over 50% of time) feels guilty about past 
    actions the significance of which he exaggerates. 
3. Severe Subject usually feels s/he is to blame for everything that has 
    gone wrong, even when not his/her fault. 
 
6. MORNING DEPRESSION : When you have felt depressed over the last 
2 weeks have you noticed the depression being worse at any 
particular  time of the day? 
0. Absent No depression. 
1. Mild Depression present but no diurnal variation. 
2. Moderate Depression spontaneously mentioned to be worse in a.m. 
3. Severe Depression markedly worse in a.m., with impaired functioning 
    which improves in p.m. 
 
7. EARLY MORNING AWAKENING : Do you wake earlier in the 
morning than is normal for you? How many times a week does this 
happen? 
0.  Absent No early wakening.  
1.  Mild Occasionally wakes (up to twice weekly) 1 hour or more before 
     normal time to wake or alarm time 
2. Moderate Often wakes early (up to 5 times weekly) 1 hour or more 
     before normal time to wake or alarm. 
3. Severe Daily wakes 1 hour or more before normal time. 
 
8. S UICIDE : Have you felt that life wasn‟t worth living? Did you ever 
feel like ending it all? What did you think you might do? Did you 
actually try? 
0. Absent 
1. Mild Frequent thoughts of being better off dead, or occasional 
    thoughts of  suicide. 
2. Moderate  deliberately considered suicide with a plan, but made no 
    attempt. 
 
 3. Severe Suicidal attempt apparently designed to end in death (i.e.: 
     accidental discovery or inefficient means). 
 
9. OBSERVE  DEPRESSION : Based on interviewer‟s observations 
During  the entire interview. The question “Do you feel like crying?” 
used at appropriate points in the interview, may elicit information 
useful to this observation. 
0. Absent 
1. Mild 
2. Moderate 0. Absent 
1. Mild 
3. Severe 
 
Subject feels blamed but not accused less than 50% of the time. 
Persisting sense of being blamed, and/or occasional sense of being 
accused. 
Persistent sense of being accused. When challenged, acknowledges that 
it is not so. 
  
  
SANS: Scale for the Assessment of Negative Symptoms 
 
Patient ID 
 
Date of Birth 
 
Gender 
 
Age 
 
Initials 
 
Interview Date 
 
Scale for the Assessment of Negative Symptoms 
 
SANS CODES 
 
0 = None/Not at all 2 = Mild 4 = Marked 9 = Unknown/Cannot be 1 = 
Questionable 3 = Moderate 5 = Severe assessed/Not assessed 
 
  
 AFFECTIVE FLATTENING OR BLUNTING 
 
1. 
Unchanging Facial Expression 
None ----------> Severe  
The patient's face appears wooden-changes less than expected as emotional 
content of discourse changes. 
0 
1 
2 
3 
4 
5 
9 
 
2. Decreased Spontaneous Movements 
The patient shows few or no spontaneous movements, does not shift position, 
move extremities, etc. 
0 
1 
2 
3 
4 
5 
9 
 
3.Paucity of Expressive Gestures 
The patient does not use hand gestures or body position as an aid in expressing 
his ideas. 
0 
1 
2 
3 
4 
5 
9 
 
4. 
Poor Eye Contact 
The patient avoids eye contact or "stares through" interviewer even when 
speaking. 
0 
1 
2 
3 
 4 
5 
9 
 
5. 
Affective nonresponsivity 
The patient fails to laugh or smile when prompted. 
0 
1 
2 
3 
4 
5 
9 
 
6. 
Inappropriate Affect 
The patient's affect is inappropriate or incongruous, not simply flat or blunted. 
0 
1 
2 
3 
4 
5 
9 
 
7. 
Lack of Vocal Inflections 
The patient fails to show normal vocal emphasis patterns, is often monotonic. 
0 
1 
2 
3 
4 
5 
9 
 
8. 
Global Rating of Affective Flattening 
This rating should focus on overall severity of symptoms, especially 
unresponsiveness, inappropriateness and an overall decrease in emotional 
intensity. 
0 
1 
2 
 3 
4 
5 
9 
 
 
 
 
ALOGIA 
 
9. Poverty of Speech 
The patient's replies to questions are restricted in amount, tend to be brief, 
concrete, unelaborated. 
0 
1 
2 
3 
4 
5 
9 
 
10. Poverty of Content of Speech 
The patient's replies are adequate in amount but tend to be vague, over concrete 
or over generalized, and convey little in information. 
0 
1 
2 
3 
4 
5 
9 
 
11. Blocking 
The patient indicates, either spontaneously or with prompting, that his train of 
thought was interrupted. 
 
0 
1 
2 
3 
4 
5 
9 
 
 
 12. Increased Latency of Response 
The patient takes a long time to reply to questions, prompting indicates the 
patient is aware of the question. 
0 
1 
2 
3 
4 
5 
9 
 
13. Global Rating of Alogia 
The core features of alogia are poverty of speech and poverty of content. 
0 
1 
2 
3 
4 
5 
9 
  
 AVOLITION/APATHY 
 
14. Grooming and Hygiene 
The patient's clothes may be sloppy or soiled, and he may have greasy hair, 
body odor, etc. 
0 
1 
2 
3 
4 
5 
9 
 
15. Inpersistence at Work or School 
The patient has difficulty seeking or maintaining employment, completing 
school work, keeping house, etc. If an inpatient, cannot persist at ward 
activities, such as OT, playing cards, etc 
0 
1 
2 
3 
4 
5 
9 
16. Physical Anergia 
The patient tends to be physically inert. He may sit for hours and not initiate 
spontaneous activity. 
0 
1 
2 
3 
4 
5 
9 
17. Global Rating of Avolition/Apathy 
Strong weight may be given to one or two prominent symptoms if particularly 
striking. 
0 
1 
2 
3 
4 
5 
9 
 
 ANHEDONIA/ASOCIALITY 
 
18.Recreational Interests and Activities 
The patient may have few or no interests. Both the quality and quantity of 
interests should be taken into account. 
0 
1 
2 
3 
4 
5 
9 
 
19. 
Sexual Activity 
 
The patient may show decrease in sexual interest and activity, or no enjoyment 
when active. 
0 
1 
2 
3 
4 
5 
9 
 
20. 
Ability to Feel Intimacy and Closeness 
The patient may display an inability to form close or intimate relationships, 
especially with opposite sex and family. 
0 
1 
2 
3 
4 
5 
9 
 
21. 
Relationships with Friends and Peers 
The patient may have few or no friends and may prefer to spend all his time 
isolated. 
0 
1 
2 
 3 
4 
5 
9 
 
22. 
Global Rating of Anhedonia/Asociality 
This rating should reflect overall severity, taking into account the patient's age, 
family status, etc. 
0 
1 
2 
3 
4 
5 
9 
 
 
 
  
 ATTENTION 
 
23. Social Inattentiveness 
The patient appears uninvolved or unengaged. He may seem "spacey". 
0 
1 
2 
3 
4 
5 
9 
24. Inattentiveness During Mental Status Testing 
Refer to tests of "serial 7s" (at least five subtractions) and spelling "world" 
backwards. 
0 
1 
2 
3 
4 
5 
9 
25. Global Rating of Attention 
This rating should assess the patient's overall concentration, both clinically and 
on tests. 
0 
1 
2 
3 
4 
5 
9 
 
 SCALE FOR ASSESSMENT OF POSITIVE SYMPTOMS 
 
SAPS CODES 
 
0 = None/Not at all 2 = Mild 4 = Marked 9 = Unknown/Cannot be 1 = 
Questionable 3 = Moderate 5 = Severe assessed/Not assessed 
 
1. 
Auditory Hallucinations 
None ----------> Severe Unk 
The patient reports voices, noises, or other sounds that no one else hears. 
0 
1 
2 
3 
4 
5 
9 
2. Voices Commenting 
The patient reports a voice which makes a running commentary on his behavior 
or thoughts. 
0 
1 
2 
3 
4 
5 
9 
3. 
Voices Conversing 
The patient reports hearing two or more voices conversing. 
0 
1 
2 
3 
4 
5 
9 
4. 
Somatic or Tactile Hallucinations 
The patient reports experiencing peculiar physical sensations in the body. 
0 
1 
2 
3 
 4 
5 
9 
5. 
Olfactory Hallucinations 
The patient reports experiencing unusual smells which no one else notices. 
0 
1 
2 
3 
4 
5 
9 
6. 
Visual Hallucinations 
The patient sees shapes or people that are not actually present. 
0 
1 
2 
3 
4 
5 
9 
7. 
Global Rating of Hallucinations 
This rating should be based on the duration and severity of the hallucinations and 
their effects on the patient's life. 
0 
1 
2 
3 
4 
5 
9 
8. 
Persecutory Delusions 
 
The patient believes he is being conspired against or persecuted in some way. 
0 
1 
2 
3 
4 
5 
9 
 9. 
Delusions of Jealousy 
The patient believes his spouse is having an affair with someone. 
0 
1 
2 
3 
4 
5 
9 
10. Delusions of Guilt or Sin 
The patient believes that he has committed some terrible sin or done something 
unforgivable. 
0 
1 
2 
3 
4 
5 
9 
11. 
Grandiose Delusions 
The patient believes he has special powers or abilities. 
0 
1 
2 
3 
4 
5 
9 
12. 
Religious Delusions 
The patient is preoccupied with false beliefs of a religious nature. 
0 
1 
2 
3 
4 
5 
9 
13. 
Somatic Delusions 
The patient believes that somehow his body is diseased, abnormal, or changed. 
0 
1 
 2 
3 
4 
5 
9 
14. 
Delusions of Reference 
The patient believes that insignificant remarks or events refer to him or have 
special meaning. 
0 
1 
2 
3 
4 
5 
9 
15. 
Delusions of Being Controlled 
The patient feels that his feelings or actions are controlled by some outside 
force. 
0 
1 
2 
3 
4 
5 
9 
16. 
Delusions of Mind Reading 
The patient feels that people can read his mind or know his thoughts. 
0 
1 
2 
3 
4 
5 
9 
17. 
Thought Broadcasting 
The patient believes that his thoughts are broadcast so that he himself or others 
can hear them. 
0 
1 
2 
3 
 4 
5 
9 
18. 
Thought Insertion 
The patient believes that thoughts that are not his own have been inserted into 
his mind. 
0 
1 
2 
3 
4 
5 
9 
19. 
Thought Withdrawal 
The patient believes that thoughts have been taken away from his mind. 
0 
1 
2 
3 
4 
5 
9 
20. 
Global Rating of Delusions 
This rating should be based on the duration and persistence of the delusions and 
their effect on the patient's life. 
0 
1 
2 
3 
4 
5 
9 
 
 
 
21. 
Clothing and Appearance 
The patient dresses in an unusual manner or does other strange things to alter 
his appearance. 
0 
1 
2 
 3 
4 
5 
9 
22. 
Social and Sexual Behavior 
 
The patient may do things considered inappropriate according to usual social 
norms (e.g., masturbating in public). 
0 
1 
2 
3 
4 
5 
9 
23. 
Aggressive and Agitated Behavior 
The patient may behave in an aggressive, agitated manner, often unpredictably. 
0 
1 
2 
3 
4 
5 
9 
24. 
Repetitive or Stereotyped Behavior 
The patient develops a set of repetitive actions or rituals that he must perform 
over and over. 
0 
1 
2 
3 
4 
5 
9 
25. 
Global Rating of Bizarre Behavior 
This rating should reflect the type of behavior and the extent to which it deviates 
from social norms. 
0 
1 
2 
3 
 4 
5 
9 
26. 
Derailment 
A pattern of speech in which ideas slip off track onto ideas obliquely related or 
unrelated. 
0 
1 
2 
3 
4 
5 
9 
27. 
Tangentiality 
The patient replies to a question in an oblique or irrelevant manner. 
0 
1 
2 
3 
4 
5 
9 
28. 
Incoherence 
A pattern of speech that is essentially incomprehensible at times. 
0 
1 
2 
3 
4 
5 
9 
29. 
Illogicality 
A  pattern of speech in which conclusions are reached that do not follow 
logically. 
0 
1 
2 
3 
4 
5 
9 
 30. 
Circumstantiality 
A pattern of speech that is very indirect and delayed in reaching its goal idea. 
0 
1 
2 
3 
4 
5 
9 
31. 
Pressure of Speech 
The patient's speech is rapid and difficult to interrupt; the amount of speech 
produced is greater than that considered normal. 
0 
1 
2 
3 
4 
5 
9 
32. 
Distractible Speech 
The patient is distracted by nearby stimuli which interrupt his flow of speech. 
0 
1 
2 
3 
4 
5 
9 
33. 
Clanging 
A  pattern of speech in which sounds rather than meaningful relationships 
govern word choice. 
0 
1 
2 
3 
4 
5 
9 
  
 34. 
Global Rating of Positive Formal Thought Disorder 
The frequency of this rating should reflect the frequency of abnormality and 
degree to which it affects 
0 
1 
2 
3 
4 
5 
9 
the patient's ability to communicate. 
  
 The scale of suicidal ideation 
 
The scale of suicidal ideation consists of 19 items which can be used to 
evaluate a patient's suicidal intentions. It can also be used to monitor a 
patient's response to interventions over time. 
Item Response Points 
 
1. Wish to live moderate to strong 0 
 weak 1 
 none 2 
 
2. Wish to die none 0 
 weak 1 
 moderate to strong 2 
 
3. Reasons for living/dying for living outweigh for dying 0 
 about equal 1 
 for dying outweigh for living 2 
 
4. Desire to make active 
suicide attempt 
none 0 
 weak 1 
 moderate to strong 2 
 
5. Passive suicidal desire 
would take precautions to save 
life 
0 
 
would leave life/death to 
chance 
1 
 
would avoid steps necessary to 
save or maintain life 
2 
 
6. Duration of suicide 
ideation/ wish 
brief fleeting periods 0 
 longer periods 1 
 
continuous (chronic) or almost 
continuous 
2 
 
 
7. Frequency of suicide rare occasional 0 
 ideation 
 intermittent 1 
 persistent or continuous 2 
 
8. Attitude toward 
ideation/wish 
rejecting 0 
 ambivalent indifferent 1 
 accepting 2 
 
9. Control over suicidal 
action/ acting-out wish 
has sense of control 0 
 unsure of control 1 
 has no sense of control 2 
 
10. Deterrents to active 
attempt 
would not attempt because of a 
deterrent 
0 
 some concern about deterrents 1 
 
minimal or no concern about 
deterrents 
2 
 
11. Reason for contemplated 
attempt 
to manipulate the environment; 
get attention or revenge 
0 
 
combination of desire to 
manipulate and to escape 
1 
 
escape surcease solve 
problems 
2 
 
12. Method: specificity or 
planning of contemplated 
attempt 
not considered 0 
 
considered but details not 
worked out 
1 
 
details worked out and well-
formulated 
2 
 
13. Method: availability or 
opportunity for 
contemplated attempt 
method not available or no 
opportunity 
 
 
0 
 
method would take time or 
effort; opportunity not readily 
1 
 available 
 
method and opportunity 
available 
2 
 
future opportunity or 
availability of method 
anticipated 
2 
 
14. Sense of "capability" to 
carry out attempt 
no courage too weak afraid 
incompetent 
0 
 
unsure of courage or 
competence 
1 
 sure of competence courage 2 
 
15. Expectancy/anticipation 
of actual attempt 
no 0 
 uncertain not sure 1 
 yes 2 
 
16. Actual preparation for 
contemplated attempt 
none 0 
 partial 1 
 complete 2 
 
17. Suicide note none 0 
 
started but not completed; only 
thought about 
1 
 completed 2 
18. Final acts in anticipation 
of death 
none 0 
 
thought about or made some 
arrangements 
1 
 
made definite plans or 
completed arrangements 
2 
19. Deception or concealment 
of contemplated suicide 
revealed ideas openly 0 
 held back on revealing 1 
 
attempted to deceive conceal 
or lie 
2 
 
Scoring: 
  
The total score for the 19 items is calculated. 
Minimum score = 0 
Maximum score = 38 
Higher scores indicate greater suicidal ideation 
References: 
 
Beck AT Kovacs M Weissman A. Assessment of suicidal intention: The 
scale of suicide ideation. J Consult Clin Psychology. 1979; 47: 343-352. 
Beck AT Steer RA Rantieri WF. Scale for suicide ideation: Psychometric 
properties of a self-report version. J Clin Psychology. 1988; 44: 499-505. 
It has a reliability coefficient of 0.89. The interrater reliability coefficient was 
0.83 (p < .001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  
  
 
ABBREVIATION 
 
 
5- HIAA  - 5-Hydroxy Indole acetic acid 
 
TPH Gene  - Tryptophan  hydroxylase gene 
 
STP Gene  - Serotonin transporter gene 
 
ASPD  - Anti – social  personality disorder 
 
DLPFC  - Dorsolateral pre frontal cortex 
 
SAPS   - Scale for the assessment of positive  
     symptoms 
 
SANS  - Scale for the assessment of  negative 
     symptoms 
 
CDSS  - The Calgory Depression rating Scale for  
    Schizophrenia 
 
BSIS   - Beck‟s Suicide Intent Scale 
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14
2 
99 16   30 
4 1 1 1 1 2 3 1 2         2 12 86 12   26 
 8 
4 1 2 2 2 2 3 1 2           78 32 3     
4 1 2 1 1 2 4 1 2         4 
14
2 
100 19   31 
4 2 2 2 2 2 3 1 2           74 35 2     
4 1 2 2 2 2 3 1 2           72 33 3     
4 1 2 1 2 2 3 1 2         3 
11
6 
78 9   28 
4 1 2 1 1 2 3 1 2         3 
12
8 
80 10   26 
4 2 2 2 2 2 2 1 2           84 36 2     
4 2 2 2 2 2 4 1 2           78 34 3     
4 2 2 1 1 2 3 1 2         1 
13
6 
86 14   28 
4 2 2 2 2 2 3 1 2           72 28 2     
4 1 2 1 1 2 3 1 2         3 
14
2 
96 12   31 
4 5 1 2 2 1 4 1 2           76 23 2     
4 2 1 1 2 2 4 1 2         2 
13
2 
98 15   30 
4 1 2 1 2 2 4 1 2         3 
12
2 
91 12   22 
4 1 2 1 1 1 3 2 2         1 
12
4 
88 14   24 
4 2 2 2 2 2 3 1 2           82 33 2     
4 2 2 1 2 1 3 1 2         3 
11
4 
86 15   26 
 4 1 2 2 2 2 3 1 2           78 24 2     
4 2 2 1 1 2 3 1 2         3 
12
3 
93 16   26 
4 1 2 2 2 2 4 1 2           76 32 2     
4 1 2 2 2 2 4 1 2           78 33 2     
2 2 1 1 2 2 4 1 1 1 3 4 2   
14
8 
98 17 12 30 
4 1 2 1 2 2 4 1 2           73 37 2     
4 1 2 2 2 2 4 1 2           68 36 3     
4 1 2 1 1 2 4 1 2         2 
11
2 
89 10   27 
4 1 2 2 2 2 3 1 2           74 43 5     
4 1 2 1 1 2 3 1 2         1 
12
3 
91 12   30 
4 1 1 2 2 2 2 1 2           79 41 3     
4 1 2 2 2 2 4 1 2           78 41 4     
3 1 2 2 2 2 2 1 2           80 49 4     
4 1 2 2 2 2 3 1 2           84 45 4     
4 1 2 2 2 2 4 1 2           80 47 4     
 
 
